Serine Hydroxymethyl Transferase 1 Stimulates Pro-oncogenic Cytokine Expression Through Sialic Acid to Promote Ovarian Cancer Tumor Growth and Progression

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2017 Mar 14

PMID 28288142

Citations 22

Authors

R Gupta

Q Yang

S K Dogra

N Wajapeyee

Affiliations

Soon will be listed here.

Abstract

High-grade serous (HGS) ovarian cancer accounts for 90% of all ovarian cancer-related deaths. However, factors that drive HGS ovarian cancer tumor growth have not been fully elucidated. In particular, comprehensive analysis of the metabolic requirements of ovarian cancer tumor growth has not been performed. By analyzing The Cancer Genome Atlas mRNA expression data for HGS ovarian cancer patient samples, we observed that six enzymes of the folic acid metabolic pathway were overexpressed in HGS ovarian cancer samples compared with normal ovary samples. Systematic knockdown of all six genes using short hairpin RNAs (shRNAs) and follow-up functional studies demonstrated that serine hydroxymethyl transferase 1 (SHMT1) was necessary for ovarian cancer tumor growth and cell migration in culture and tumor formation in mice. SHMT1 promoter analysis identified transcription factor Wilms tumor 1 (WT1) binding sites, and WT1 knockdown resulted in reduced SHMT1 transcription in ovarian cancer cells. Unbiased large-scale metabolomic analysis and transcriptome-wide mRNA expression profiling identified reduced levels of several metabolites of the amino sugar and nucleotide sugar metabolic pathways, including sialic acid N-acetylneuraminic acid (Neu5Ac), and downregulation of pro-oncogenic cytokines interleukin-6 and 8 (IL-6 and IL-8) as unexpected outcomes of SHMT1 loss. Overexpression of either IL-6 or IL-8 partially rescued SHMT1 loss-induced tumor growth inhibition and migration. Supplementation of culture medium with Neu5Ac stimulated expression of IL-6 and IL-8 and rescued the tumor growth and migratory phenotypes of ovarian cancer cells expressing SHMT1 shRNAs. In agreement with the ovarian tumor-promoting role of Neu5Ac, treatment with Neu5Ac-targeting glycomimetic P-3Fax-Neu5Ac blocked ovarian cancer growth and migration. Collectively, these results demonstrate that SHMT1 controls the expression of pro-oncogenic inflammatory cytokines by regulating sialic acid Neu5Ac to promote ovarian cancer tumor growth and migration. Thus, targeting of SHMT1 and Neu5Ac represents a precision therapy opportunity for effective HGS ovarian cancer treatment.

Citing Articles

Integrative bioinformatics approach identifies novel drug targets for hyperaldosteronism, with a focus on SHMT1 as a promising therapeutic candidate.

Jia M, Lin L, Yu H, Dong Z, Pan X, Song X Sci Rep. 2025; 15(1):1690.

PMID: 39799159 PMC: 11724956. DOI: 10.1038/s41598-025-85900-8.

Metabolomic Analysis of Histological Composition Variability of High-Grade Serous Ovarian Cancer Using H HR MAS NMR Spectroscopy.

Skorupa A, Klimek M, Ciszek M, Pakulo S, Cichon T, Cichon B Int J Mol Sci. 2024; 25(20).

PMID: 39456684 PMC: 11507550. DOI: 10.3390/ijms252010903.

Mixed-phase weak anion-exchange/reversed-phase LC-MS/MS for analysis of nucleotide sugars in human fibroblasts.

Rahm M, Kwast H, Wessels H, Noga M, Lefeber D Anal Bioanal Chem. 2024; 416(15):3595-3604.

PMID: 38676823 PMC: 11156716. DOI: 10.1007/s00216-024-05313-w.

HOXD8 suppresses renal cell carcinoma growth by upregulating SHMT1 expression.

Yang Y, Zhang M, Zhao Y, Deng T, Zhou X, Qian H Cancer Sci. 2023; 114(12):4583-4595.

PMID: 37752684 PMC: 10728000. DOI: 10.1111/cas.15982.

Metabolic reprogramming of three major nutrients in platinum-resistant ovarian cancer.

Yan J, Xu F, Zhou D, Zhang S, Zhang B, Meng Q Front Oncol. 2023; 13:1231460.

PMID: 37681030 PMC: 10482409. DOI: 10.3389/fonc.2023.1231460.

References

Lin L, Chamberlain L, Pak M, Nagarajan A, Gupta R, Zhu L . A large-scale RNAi-based mouse tumorigenesis screen identifies new lung cancer tumor suppressors that repress FGFR signaling. Cancer Discov. 2014; 4(10):1168-81. PMC: 4184919. DOI: 10.1158/2159-8290.CD-13-0747. View

Paone A, Marani M, Fiascarelli A, Rinaldo S, Giardina G, Contestabile R . SHMT1 knockdown induces apoptosis in lung cancer cells by causing uracil misincorporation. Cell Death Dis. 2014; 5:e1525. PMC: 4260740. DOI: 10.1038/cddis.2014.482. View

Wu S, Zhang G, Li P, Chen S, Zhang F, Li J . miR-198 targets SHMT1 to inhibit cell proliferation and enhance cell apoptosis in lung adenocarcinoma. Tumour Biol. 2015; 37(4):5193-202. DOI: 10.1007/s13277-015-4369-z. View

Cannistra S . Cancer of the ovary. N Engl J Med. 2004; 351(24):2519-29. DOI: 10.1056/NEJMra041842. View

Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba M . PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002; 18(2):333-4. DOI: 10.1093/bioinformatics/18.2.333. View

Forloni M, Gupta R, Nagarajan A, Sun L, Dong Y, Pirazzoli V . Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells. Cell Rep. 2016; 16(2):457-471. PMC: 4945411. DOI: 10.1016/j.celrep.2016.05.087. View

Possemato R, Marks K, Shaul Y, Pacold M, Kim D, Birsoy K . Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011; 476(7360):346-50. PMC: 3353325. DOI: 10.1038/nature10350. View

Pabalan N, Jarjanazi H, Ozcelik H . A meta-analysis of the C1420T polymorphism in cytosolic serine hydroxymethyltransferase (SHMT1) among Caucasian colorectal cancer populations. Int J Colorectal Dis. 2013; 28(7):925-32. DOI: 10.1007/s00384-013-1639-3. View

Chen B, Liang Y, He Z, An Y, Zhao W, Wu J . Autocrine activity of BDNF induced by the STAT3 signaling pathway causes prolonged TrkB activation and promotes human non-small-cell lung cancer proliferation. Sci Rep. 2016; 6:30404. PMC: 4960652. DOI: 10.1038/srep30404. View

10.

Yang L, Moss T, Mangala L, Marini J, Zhao H, Wahlig S . Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer. Mol Syst Biol. 2014; 10:728. PMC: 4188042. DOI: 10.1002/msb.20134892. View

11.

Westbrook T, Martin E, Schlabach M, Leng Y, Liang A, Feng B . A genetic screen for candidate tumor suppressors identifies REST. Cell. 2005; 121(6):837-48. DOI: 10.1016/j.cell.2005.03.033. View

12.

Waugh D, Wilson C . The interleukin-8 pathway in cancer. Clin Cancer Res. 2008; 14(21):6735-41. DOI: 10.1158/1078-0432.CCR-07-4843. View

13.

Zhang S, Hui L, Li C, Gao J, Cui Z, Qiu X . More expression of BDNF associates with lung squamous cell carcinoma and is critical to the proliferation and invasion of lung cancer cells. BMC Cancer. 2016; 16:171. PMC: 4772289. DOI: 10.1186/s12885-016-2218-0. View

14.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

15.

Wang Y, Zhang S, Xue W, Zhu M, Zheng L . SHMT1 C1420T polymorphism contributes to the risk of non-Hodgkin lymphoma: evidence from 7309 patients. Chin J Cancer. 2015; 34(12):573-82. PMC: 4699293. DOI: 10.1186/s40880-015-0065-z. View

16.

Williams S, Cvetkovic D, Hamilton T . Vitamin A metabolism is impaired in human ovarian cancer. Gynecol Oncol. 2008; 112(3):637-45. PMC: 2737361. DOI: 10.1016/j.ygyno.2008.11.015. View

17.

Miranda F, Mannion D, Liu S, Zheng Y, Mangala L, Redondo C . Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche. Cancer Cell. 2016; 30(2):273-289. DOI: 10.1016/j.ccell.2016.06.020. View

18.

Lane A, W-M Fan T . Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res. 2015; 43(4):2466-85. PMC: 4344498. DOI: 10.1093/nar/gkv047. View

19.

Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M . IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest. 2007; 117(12):3988-4002. PMC: 2096439. DOI: 10.1172/JCI32533. View

20.

Bahari G, Hashemi M, Naderi M, Sadeghi-Bojd S, Taheri M . Association of SHMT1 gene polymorphisms with the risk of childhood acute lymphoblastic leukemia in a sample of Iranian population. Cell Mol Biol (Noisy-le-grand). 2016; 62(2):45-51. View